Format

Send to

Choose Destination
Neurology. 2001 Aug 14;57(3):548-50.

A prospective natural history study of inclusion body myositis: implications for clinical trials.

Author information

1
Department of Neurology, King's Neurosciences Centre, King's College Hospital, London, UK. m.r.rose@kcl.ac.uk

Abstract

Eleven patients with untreated inclusion body myositis (IBM) were prospectively studied during a 6-month period that included muscle strength, lean body mass, and muscle mass measurements. There was an overall quantifiable mean decline in percent of predicted normal muscle strength of 4% from baseline in a 6-month period, but one third of patients showed no change or slight improvements in strength. Short-term treatment trials in IBM will require large numbers of patients to detect slowing, arrest, or even slight improvement in muscle strength.

PMID:
11502935
DOI:
10.1212/wnl.57.3.548
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center